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ABSTRACT
Introduction: The development of  squamous cell carcinoma of  oral cavity (SCC) is a multifactorial process, where the cellular
mutagenesis is determined by co-carcinogenetic agents like the human papillomavirus (HPV). Objective: the objective of  this
study is to identify the HPV in the SCC by means of  polymerase chain reaction (PCR). Methods: twenty cases of  SCC have
been analyzed where the material used was extracted from specimens included in paraffin blocks of  the Pathology Laboratory
file of  the São Vicente de Paulo Hospital of  Passo Fundo/RS in the period of  2003 to 2007. They were all male cases and
the 6th decade of  life was the most prevalent. The lower lip was the region that comprises most of  the defects and the
histological grade “well-differentiated” from the World Health Organization was predominant. It has been detected the presence
of   HPV’s DNA in four of  the 20 cases of  the SCC (20%). Conclusions: it can be assured that, by the fact of  the HPV has
been identified in a considerable percentage of  cases of  SCC, it can have influence on the genesis of  the referred malignant
neoplasia. So, more studies are necessary to define what is the possible role of  HPV in the oral carcinogenesis.
Keywords: Oral cancer. HPV. PCR.
RESUMO
Introdução: O desenvolvimento do carcinoma de células escamosas da cavidade bucal (CCECV) constitui-se num processo
multifatorial, no qual a mutagênese celular é determinada por agentes co-carcinogênicos como o papilomavirus humano
(HPV). Objetivo: o objetivo deste estudo é identificar o HPV no CCECV por meio da reação de cadeia em polimerase
(PCR). Métodos: vinte casos de CCECV foram analisados, tendo sido o material utilizado extraído de espécimes incluídos
em blocos de parafina do arquivo do Laboratório de Patologia do Hospital São Vicente de Paulo de Passo Fundo/RS no
período de 2003 a 2007. Todos os casos levantados pertenciam a pacientes do sexo masculino e a sexta década de vida foi
a mais prevalente. O lábio inferior foi a região que apresentou o maior número de lesões e o grau histológico “bem
diferenciado” da Organização Mundial da Saúde foi predominante. Detectou-se a presença de DNA do HPV em quatro dos
vinte casos de CCECV estudados (20%). Conclusões: pode-se concluir que, pelo fato do HPV ter sido identificado numa
porcentagem significativa de casos de CCECB, ele pode ter influência na origem da referida neoplasia maligna. No entanto,
mais estudos são necessários para definir qual é o possível papel do HPV na carcinogênese bucal.
Palavras-chave: Câncer bucal. HPV. PCR.
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INTRODUCTION
The oral epithelium is formed by a basal or
germinative layer that composes the most pro-
found area, limited to the chorion, and by a
prickly layer composed by various stratums of
several strata of  poliedric cells. Basal cells are
more undifferentiated and the richest in metabolic
activity as well10.
Cells multiplication is carefully regulated and
it responds to body specific needs. Therefore,
when the special controls which regulate cell
multiplication collapses, the cell begins to grow
and divide in such irregular manner, then forming
a tumoral mass. Multiple mutations are necessary
so that a normal cell becomes malignant4.
Human cell regulation with the virus may be
caused by the cellular fusion, by believing that, by
means of  this process, the virus contributes to
carcigenesis29.  It is estimated that 15% of  all human
cancers in the world can be attributed to the virus12.
The DNA as well as the RNA virus have shown
that they are able to cause cancer in human beings.
The Epstein-Barr virus, the human papillomavirus
(HPV), hepatitis B virus and human-8 herpes virus
are the four DNA virus that are involved in car-
cinogenesis. But the RNA virus linked to this proc-
ess is the human virus T-lymphotropic type 1 and
the one of  the hepatitis C3.
The association of  the HPV oncogenic with
the cervix carcinoma is already well-established27,
however, the relation of  this pathogen with the
SCC is still uncertain, and it has been documented
by several researchers9,11,13,23,26,28. About 100 types
of  HPV have been identified, where in the oral
cavity the HPVs 6, 11, 16 and 18 were the most
prevalent18. Fifteen types of  HPV have been clas-
sified as high risk (16, 18, 31, 33, 35, 39, 45, 51, 52,
56, 58, 59, 68, 73 and 82) for cervix cancer24.
To the idenfication of  different types of  HPV
in lesions, it is necessary a precise methodology
that combines the general detection of  the HPV
and its genotyping. In this sense, among all DNA
detection techniques of  the HPV, the polymerase
chain reaction (PCR) is the most sensitive1. The
advance in the field of  genetic and molecular bi-
ology allows that, by means of  this technique, the
use of  scarce sources such as tissue fixed in
formol and included in paraffin5,8,15.
Before such presuppositions, the objective of
this present study was to identify in 20 samples
of  SCC recorded in the Pathology Laboratory file
of  the São Vicente de Paulo Hospital of  Passo
Fundo/RS (PLHSVP) (period of 2003 to 2007),
the presence of HPV through application of the
PCR, in order to correlate this virus with the in-
firmity in study.
MATERIAL AND METHODS
Ethical considerations
This work was submitted and aproved for the
Research Ethical Comitee of  University of  Passo
Fundo, RS, Brazil (protocol number 333/2006).
Clinical samples
Twenty fragments of  SCC fixed in formol
10% and embedded in paraffin, randomly col-
lected in the files of  the PLHSVP, in the period
of  2003 and 2007, with data related to age,
gender, anatomical location and histological
grade of  neoplasia were used, according to the
WHO. Paraffin blocks comprising tissue sam-
ples of  biopsy concerning each case have been
cut in microtome in 10 ì m thickness until it
has obtained 30 to 40 mg of  material, which
were stored inside  micro-tubes with 2.000 ì L,
capacity, type Eppendorf.
Cuts preparation
The material stored in the micro-tubes was
submitted, twice, to a bath of  1.000 ìl xilol for 30
min at 65°C, centrifuged at 14.000 rpm per 5 min,
discharging the supernatants in both stages. After
it has been paraffin embedded, the tissue was hy-
drated in ethyl alcohol descendent chain (absolute
ethanol 95%, ethanol 70%) and deionized water. In
each one of  the stages, the material was centri-
fuged at 14.000 rpm for 5 min, and the
supernatant discharged.
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DNA extraction
The protocol used for extraction of  the DNA
of  the SCC cases was based on the information
provided by the manufacturer of  the extraction kit
of the DNA Wizard Genomic Purification™
(Promega Corporation, Madison, WI, USA), with
some modifications to the technique optimization.
From the material hydrated, proteins digestion and
the extraction itself  of  the DNA have begun. For
this, 600 ì L cellular lysis and 300 ì L nuclear lysis
solutions were added, incubating at 65°C for 60 min.
The digestion of  the proteins was accomplished by
adding a solution of proteinase K (10 ì g/ì L), in a
proportion of  3,5 ì L of  the solution to each 1 mg
of  paraffin material, incubating overnight at
50°C”60°C. After that, it has been added 3 ìL of
RNase solution and incubated for 15 to 30 min at
37ºC. In the next stage, 200 ì L of  protein precipi-
tation solution was added, homogenized with vor-
tex, 15 min in ice was incubated, centrifuged at
14.000 rpm for 4 min and the supernatant trans-
ferred to a new tube of  2.000 ì L containing 600 ì L
of  isopropanol, inverting it softly from 5 to 6 times.
After, it was centrifuged at 14.000 rpm for 5 min.
Then, the supernatant was removed, adding 600 ì L
ethanol 70% iced. Subsequently, it was centrifuged at
14.000 rpm for more than 5 min; the tubes were
inverted on the towel-paper and left open for 15
min to dry. Next, 100 ì L rehydration solution of
DNA was added, incubating for 1h at 65°C. These
samples were stored at 4°C.
DNA amplification
In this work, the concensus primers MY09:
5\\’ CGTCCMAARGGAWACTGATC3\\’ and
MY11: 5\\’ GCMCAGGGWCATAAYAATGG
3\\’ were used, which specifically enlarge a part of
the gene L119. The reaction of  amplification was
accomplished in final volume of  50 ì L, being
comprised of 5 ì L tampon 10x, 2.5 ì L of MgCl2,
200 ì M of  each deoxynucleotidyl-tranferase (TdT),
12.5 pmoles of  each primer and 3 U of  Taq DNA
polymerase. For each amplification reaction, 5 ì L
of  the solution were used, containing the DNA
previously extracted. In each amplification battery
by the PCR, a negative control has always been
used (water MiliQ) and positive (sample of  HPV
positive ceded by the Simbios Biotechnology Labo-
ratory), comprised of  the same concentrations and
same reagents of  the amplification reaction, except
the DNA. The amplification system of  the DNA
was achieved in tubes of  200 ì L, which were
transferred to the thermocycler (MJ Research PTC
150). The PCR program was consisted of  the fol-
lowing stages: 95ºC for 5 min, 40 amplification
cycles (95ºC for 1 min, 55ºC for 1 min, 72 ºC for
1 min) and 72ºC for 5 min, according to what has
been described by BAUER et al.2 (1991) and
MANOS et al.14 (1989). The product visualization
of  the PCR has been achieved in electrophoresis
of  agar gel (1% in TA) stained with ethidium bro-
mide under UV light.
The results obtained have been evaluated by
means of  descriptive statistics of  frequency.
RESULTS
From the total of  20 cases evaluated, all were
male, the 6th decade of  life was the most prevalent,
the lower lip was the anatomical region that has
been most affected and the histological grade of
the WHO “well-differentiated” was the prevalent.
The presence of  DNA viral (HPV) occurred in 4
of  the 20 cases of  SCC, totalizing 20% (Table 1
and Fig. 1).
FIGURE 1 – Photography of  some SCC cases submitted
to evaluation through electrophoresis method after the
DNA extraction and identification of the HPV (from left
to right: negative control, positive control, two SCC cases
without presence of  the HPV, two cases of  SCC with
presence of the HPV)
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Indicators: male *, female **; 1-floor, 2-lower lip, 3-oropharynx,
4-tongue border, 5-soft palate, 6-retromolar; 1 - WHO I, 2 – WHO
II, 3 – WHO III; + = HPV positive, - = HPV negative; DND –
non-avialble
DISCUSSION
The carcinogenesis is a process in which sev-
eral genetic events that change the normal func-
tions of  the proto-oncogenes and tumor suppres-
sor genes, occurs. This may result in an increase of
the growth factors production or the number of
the cellular surface receptors, in the reinforcement
of  the messenger intracellular signaling and / in
the increase of transcription factors production10.
The relationship of  the HPV with the SCC
has been supported by the high risk capacity of
the HPVs (16 and 18) of increasing the cellular
proliferation in vitro20.
In the present study, the presence of  the DNA
viral (HPV) in 4 of  the 20 cases of  SCC, diag-
nosed by the PCR was identified, totalizing 20%.
This way, it can be assured that, due to the HPV
has been identified in a considerable percentage of
SCC cases, it may have influence on the genesis of
the referred malignant neoplasia. Yet, it is asserted
that there was no correlation of  the presence of
the HPV as for gender, age, anatomical location
and histological grade in the samples studied.
KREIMER et al.11 (2005) have reviewed 60
studies of  PCR in oral carcinoma of  oropharynx
and larynx, where 35 works related the HPV with
the SCC, corresponding to 2.642 of  the cases
studied. So, the average found of  HPV in SCC
was 23.5%. The HPV 16 was the most prevalent,
corresponding to 68.2% of  the HPVs presented
in the SCC.
PINTOS et al.19 (2007) have evaluated 72
cases of  oral cancer and oropharynx by means of
the PCR, detecting the HPV in 14 cases (19.4%),
where the HPV 16 was the most prevalent with 8
cases (11.1%).
SMITH et al.22 (2004) have investigated the re-
lationship of  the HPV in head and neck cancer by
means of  the PCR, verifying the presence of  HPV
in 22.9% of  the 201 patients evaluated. The HPV
16 was the most prevalent with 85% of  the cases.
GONZALEZ7 (2007) have verified the pres-
ence of  HPV by means of  the PCR in 7 of  the
16 SCC samples analyzed (43.7%). The HPV 16
was the most prevalent in lesions.
RIVERO and NUNES21 (2006) have corre-
lated 40 samples of SCC with the presence of
HPV by means of  the PCR, not identifying the
presence of  HPV in any of  the samples.
All studies previously described were carried
out with the PCR and presented results related to
the presence of HPV in SCC similar to those
obtained in the present work (20% of  the cases).
The PCR was invented by the scientist Kary
Mullis in 198316,17, being considered as the best
method developed and widely used for amplifica-
tion of  nucleic acids, providing great sensitivity
and keeping high specificity25.
Nevertheless, other techniques are used to
detect the HPV in oral cancer. XAVIER et al.28
(2005) have evaluated 20 cases of  SCC, verifying
the HPV in 15 (75%), using the histopathological
examination to the presence of  koilocytosis.
TINOCO et al.26 (2004) using the immunohis-
tochemical, have analyzed 38 cases of  SCC, de-
tecting the HPV in 16 (42.5%).
TABLE 1 – Description of  the data related to age,
gender, anatomical location, histological grade and
presence of  HPV in twenty cases of  SCC analyzed
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VIDAL et al.27 (2004) when verifying the pres-
ence of  the HPV in SCC by means of  hybrid
capture have observed that from 40 individuals,
11 showed the HPV in SCC (27.5%).
In this study, it could be observed the variety
of  positiveness concerning the presence of  HPV
in SCC, what can occur due to different sizes of
samples or also, by due to the use of  methods
with variable sensitivity and specificity.
As for the type of tissue used in the study
(tissue fixed in formol and included in paraffin),
it is known that it can provide a DNA frag-
mented and/or the possibility that the formol
mediate cross reaction of  nucleic acids themselves
and with proteins. However, such conditions have
been considered in the present study, verifying
that the primordial factor that will be taken into
account, so that it can be tried to avoid such situ-
ation, is the incubation time and the temperature
in the stage of  the DNA extraction. This way, in
this study, these variables were compatible to
what has been proposed by previous studies6.
CONCLUSIONS
It is concluded that the present work have
verified the presence of  the viral DNA (HPV) in
4 of the 20 cases of SCC analyzed, totalizing
20%. Also, it has been verified that the use of
tissue fixed in formol and included in paraffin,
when the accomplishment of  retrospective labo-
ratorial researches with the PCR, is effective.
REFERENCES
1. BAREA, J.A.; PARDINI, M.I.M.C.; GUSHIKEN, T. Extração
de DNA de materiais de arquivo e fontes escassas para a utilização
em reação de polimerização em cadeia (PCR). Rev Bras Hematol,
v. 26, n. 4, p. 274-81, 2004.
2. BAUER, H.M.; TING, Y.; GREER, C.E.; CHAMBERS, J.C.;
TASHIRO, C.J.; CHIMERA, J.; REINGOLD, A.; MANOS, M.
Genital human papilomavirus infection in female university
students as determined by a PCR-based method. JAMA, v. 265, p.
472-77, 1991.
3. BOSCH, F.X.; LORINCZ, A.; MUÑOZ, N.; MEIJER, C.J.;
SHAH, K.V. The causal relation between human papillomavirus
and cervical cancer. J Clin Pathol, v. 55, n. 4, p. 244–65, 2002.
4. DUELLI, D.M.; HEARN, S.; MYERS, M.P.; LAZEBNIK, Y. A
primate virus generates transformed human cells by fusion. J Cell
Biol, v. 171, n. 3, p. 493–503, 2005.
5. FERNANDES, J.V.; MEISSNER, R.V.; FERNANDES,
T.A.A.M.; ROCHA, L.R.M.; CABRAL, M.C.; VILLA, L.L. Compa-
ração de três protocolos de extração de DNA a partir de tecido
fixado em formol e incluído em parafina. Rev Bras Patol Med
Lab, v. 40, n. 3, p. 141-46, 2004.
6. GILBERT, M.T.P.; HASELKORN, T.; BUNCE, M.; SANCHEZ,
J.J.; LUCAS, S.B.; JEWELL, L.D.; VAN MARCK, E.; WOROBEY,
M. The isolation of  nucleic acids from fixed, paraffin-embedded
tissues–which methods are useful when?. PLoS ONE, v. 2, n. 6, p.
e537, 2007.
7. GONZALEZ, J.V. Human papillomavirus in oral lesions. MED,
v. 67, p. 363-8, 2007.
8. GRAVITT, P.E.; PEYTON, C.L.; ALESSI, T.Q.; WHEELER, C.M.;
COUTLÉE, F.; HILDESHEIM, A.; SCHIFFMAN, M.H.; SCOTT,
D.R.; APPLE, R.J. Improved amplification of  genital human
papillomaviruses. J Clin Microbiol, v. 38, n. 1, p. 357–61, 2000.
9. HERRERO, R.; CASTELLSAGUÉ, X.; PAWLITA, M.;
LISSOWSKA, J.; KEE, F.; BALARAM, P.; RAJKUMAR, T.;
SRIDHAR, H.; ROSE, B.; PINTOS, J.; FERNÁNDEZ, L.; IDRIS,
A.; SÁNCHEZ, M.J.; NIETO, A.; TALAMINI, R.; TAVANI, A.;
BOSCH, F.X.; REIDEL, U.; SNIJDERS, P.J.; MEIJER, C.J.;
VISCIDI, R.; MUÑOZ, N.; FRANCESCHI, S. Human
papillomavirus and oral cancer : the International Agency for
Research on Cancer Multicenter Study. J National Cancer Inst, v.
95, n. 23, p. 1772-83, 2003.
10. KIERSZENBAUM, A. L. Histologia e biologia celular: uma
introdução à patologia. Rio de Janeiro: Elsevier Editora Ltda., 2004
11. KREIMER, A. R.; CLIFFORD, G.M.; BOYLE, P.;
FRANCESCHI, S. Human papillomavirus types in head and neck
squamous cell carcinomas worldwide: a systematic review. Cancer
Epidemiol Biom & Prevent, v. 14, p. 467-75, 2005.
12. LIAO, J. B. Viruses and human cancer. Yale J Biol Med, v. 79,
n. 3-4, p. 115–22, 2006.
13. MAGI, J.C.; BRITO, E.M.S.; GRECCO, E.T.O.; PEREIRA,
S.M.M.; FORMIGA, G.J.S. Prevalência de papilomavirus humano
(HPV) anal, genital e oral em ambulatório geral de coloproctologia.
Rev Bras Colo-proctol, v. 26, n. 3, p. 233-8, 2006.
14. MANOS, M.M.; TING, Y.; WRIGHT, D.K.; LEWIS, A.J. The
use of  polymerase chain reaction amplification for the detection of
genital human papillomaviruses. Cancer Cells Mol Diagnost
Hum Cancer, v. 7, p. 209-14, 1989.
15. MESQUITA, R.A.; ANZAI, E.K.; OLIVEIRA, R.N.; NUNES,
F.D. Avaliação de três métodos de extração de DNA de material
parafinado para amplificação de DNA genômico pela técnica da
PCR. Pesq Odontol Bras, v. 15, n. 4, p. 314-9, 2001.
16. MULLIS, K.B. The unusual origin of  the polymerase chain
reaction. Sci Am, v. 262, p. 56-65, 1990.
12 • Revista Odonto • v. 17, n. 34, jul./dez. 2009,  São Bernardo do Campo, SP, Universidade Metodista de São Paulo
Application of the PCR method for identification of the HPV in squamous cell carcinoma of the oral cavity
Recebimento:12/5/2008
Aceito: 9/1/2009
Endereço para correspondência:
João Paulo De Carli
Faculdade de Odontologia da Universidade de Passo Fundo
BR 285, Km 171, Bairro São José, Passo Fundo, RS, Brazil, Zip
Code: 99001-970
Phone/fax: (54) 3316-8403
E-mail: joaoestomatologia@yahoo.com.br or joaodecarli@upf.br
17. MULLIS, K.B.; FALOONA, F.A. Specific synthesis of  DNA in
vitro via a polymerase-catalyzed reaction. Methods Enzymol, v.
155, p. 335-50, 1987.
18. MUÑOZ, N.; BOSCH, F.X.; SANJOSÉ, S.; HERRERO, R.;
CASTELLSAGUÉ, X.; SHAH, K.V.; SNIJDERS, P.J.F.; MEIJER,
C.J.L.M. Epidemiologic classification of  human papillomavirus
types associated with cervical cancer. N Engl J Med, v. 348, p.
518–27, 2003.
19. PINTOS, J.; BLACK, M.J.; SADEGHIC, N.; GHADIRIANA,
P.; ZEITOUNIC, A.G.; VISCIDIE, R.P.; HERREROF, R.;
COUTLÉEA, F.; FRANCO, E.L. Human papillomavirus infection
and oral cancer: A case-control study in Montreal, Canada. Oral
Oncol doi:10.1016/j.oraloncology.2007.02.005.
20. REDDOUT, N.; CHRISTENSEN, T.; BUNNELL, A.;
JENSEN, D.; JOHNSON, D.; O’MALLEY, S.; KINGSLEY, K.
High risk HPV types 18 and 16 are potent modulators of oral
squamous cell carcinoma phenotypes in vitro. Infect Agent Cancer,
v. 2, n. 21, 2007. Disponível em: http://www.infectagentscancer.com.
Acesso em: 21/05/2007.
21. RIVERO, E. R. C.; NUNES, F. D. HPV in oral squamous cell
carcinomas of  a Brazilian population: amplification by PCR. Braz
Oral Res, v. 20, n. 1, p. 21-4, 2006.
22. SMITH,  E. M.; RITCHIE, J.M.; SUMMERSGILL, K.F.;
HOFFMAN, H.T.; WANG, D.H.; HAUGEN, T.H.; TUREK, L.P.
Human papillomavirus in oral exfoliated cells and risk of  head
and neck cancer. JNCI, v. 96, n. 6, p. 449-55, 2004.
23. SOARES, C. P.; MALAVAZI, I.; REIS, R.I.; NEVES, K.A.;
ZUANON, J.A.S.; BENATTI NETO, C.; SPOLIDÓRIO, L.C.;
OLIVEIRA, M.R.B. Presença do papilomavirus humano em lesões
malignas de mucosa oral. Rev Soc Bras Med Trop, v. 35, n. 5, p.
439-44, 2002.
24. SZUHAI, K.; SANDHAUS, S.M.; KOLKMAN-ULJEE, M. A
novel strategy for human papillomavirus detection and genotyping
with sybrgreen and molecular beacon polymerase chain reaction.
Am J Pathol, v. 159, n. 5, p. 1651–60, 2001.
25. TANG, Y.;  PROCOP, G.W.; PERSING, D.H. Molecular
diagnostics of  infectious diseases. Clin Chem, v. 43, p. 2021-38, 1997.
26. TINOCO, J. A.; FURTADO, A.; SILVA, C.A.B.; OLIVEIRA,
A.R. Correlação da infecção viral pelo papilomavirus humano com
as lesões papilomatosas e o carcinoma epidermóide na boca e
orofaringe. Rev Assoc Med Bras, v. 50, n. 3, p. 252-6, 2004.
27. VIDAL, A.K.L.; CALDAS JÚNIOR, A.F.; MELLO, A.R.J.;
BRANDÃO, V.R.A.; ROCHA, G.I.; TAROMARU, E. HPV detection
in oral carcinomas. J Bras Patol Med Lab, v. 40, n. 1, p. 21-6, 2004.
28. XAVIER, S.D.; FILHO, I.B.; LANCELLOTTI, C.L.P.
Prevalência de achados sugestivos de papilomavirus humano (HPV)
em biópsias de carcinoma espinocelular de cavidade bucal e
orofaringe: estudo preliminar. Rev Bras Otorrinolaringol, v. 71,
n. 4, p. 510-4, 2005.
29. ZUR, H.H. Viruses in human cancers. Science, v. 254 n. 5035,
p. 1167–73, 1991.
